PREVLAR: Phase 2a Randomized Trial to Assess the Safety and Efficacy of RRx-001 in the Attenuation of Oral Mucositis in Patients Receiving Head and Neck Chemoradiotherapy Article

cited authors

  • Bonomi, Marcelo; Blakaj, Dukagjin M.; Kabarriti, Rafi; Colvett, Kyle; Takiar, Vinita; Biagioli, Matthew; Bar -Ad, Voichita; Goyal, Sharad; Muzyka, Brian; Niermann, Kenneth; Abrouk, Nacer; Oronsky, Bryan; Reid, Tony; Caroen, Scott; Sonis, Stephen; Sher, David J.

Publication Date

  • July 1, 2023

webpage

published in

category

start page

  • 551

end page

  • 559

volume

  • 116

issue

  • 3